Journals / Retina-Vitreus / 2010 / Cilt: 18 - Sayı: 2

The development of a choroidal neovascular membrane due to Behçet’s disease

Behçet hastalığına bağlı gelişen koroidal neovasküler membran

Pages
170–173
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report in this article the clinical characteristics and treatment of two patients with a subfoveal choroidal neovascular membrane (CNVM) due to Behçet’s disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The development of a choroidal neovascular membrane due to Behçet’s disease is very rare.
📊
Key Findings & Data:The development of a choroidal neovascular membrane due to Behçet’s disease is very rare.
💡
Conclusion & Impact:We report in this article the clinical characteristics and treatment of two patients with a subfoveal choroidal neovascular membrane (CNVM) due to Behçet’s disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The development of a choroidal neovascular membrane due to Behçet’s disease is very rare. We report in this article the clinical characteristics and treatment of two patients with a subfoveal choroidal neovascular membrane (CNVM) due to Behçet’s disease.

Özet

Behçet Hastalığı (BH) nedeni ile koroidal neovasküler membran gelişmesi oldukça nadirdir. Bu makalede BH’ na bağlı subfoveal koroidal neovasküler membran (KNVM) gelişen iki olgunun klinik özellikleri ve tedavileri sunulmuştur.

🔖

Cite This Article

YÜKSEKKAYA, P., ÖZDAL, M. P. Ç., TEKE, M. Y., ÖZTÜRK, F. (2010). The development of a choroidal neovascular membrane due to Behçet’s disease. Retina-Vitreus, Cilt: 18 - Sayı: 2, 170–173. https://ajindex.com/articles/308093

References (14)

  1. O’Toole L, Tufail A, Pavesio C.: Management of choroidal neovascularization in uveitis. Int Ophthalmol Clin. 2005;45:157-177
  2. Atmaca LS, Batioğlu F, Idil A.: Retinal and disc neovascularization in Behçet’s disease and efficacy of laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1996;234:94-99
  3. Inagaki M, Harada T, Kiribuchi T, et al.: Subfoveal choroidal neovascularization in uveitis. Ophthalmologica. 1996;210:229-233
  4. Cummings HL, Rehmar AJ, Wood WJ, et al.: Long-term results of laser treatment in the ocular histoplasmosis syndrome. Arch Ophthalmol. 1995;113:465-468
  5. Macular Photocoagulation Study Group: Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol. 1991;109:1109-1114
  6. Rogers AH, Duker JS, Nichols N, et al.: Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology. 2003;110:1315-1320
  7. Wachtlin J, Heimann H, Behme T, et al.: Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol. 2003;24:899-906
  8. Rosenfeld PJ, Saperstein DA, Bressler NM, et al.: Verteporfin in Ocular Histoplasmosis Study Group. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Ophthalmology. 2004;111:1725-1733
  9. Adán A, Mateo C, Navarro R, et al.: Intravitreal bevacizumab (avastin) injection as primary treatment of inflammatory choroidal neovascularization. Retina. 2007;27:1180-1186
  10. Korobelnik JF, Hannouche D, Marin F, et al.: Surgical treatment of retrofoveal choroid neovascularization in multifocal choroiditis. J Fr Ophtalmol. 1998;21:146-151
  11. Berger AS, Conway M, Del Priore LV, et al.: Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol. 1997;115: 991-996
  12. Michelson JB, Michelson PE, Chisari FV.: Subretinal neovascular membrane and disciform scar in Behçet’s disease. Am J Ophthalmol. 1980;90:182-185
  13. Grossniklaus HE, Green WR.: Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization. Submacular Surgery Trials Research Group. Arch Ophthalmol. 1998; 116:745-749
  14. Kwak N, Okamoto N, Wood JM, et al.: VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41:3158-3164. 15.